Childhood Outcomes of Preterm Brain Abnormalities



Status:Recruiting
Conditions:Women's Studies, Women's Studies
Therapuetic Areas:Reproductive
Healthy:No
Age Range:Any - 8
Updated:2/3/2018
Start Date:February 1, 2018
End Date:January 1, 2022
Contact:Natasha Lepore, Phd
Email:nlepore@chla.usc.edu
Phone:(323) 361-5088

Use our guide to learn which trials are right for you!

Predicting the Early Childhood Outcomes of Preterm Brain Shape Abnormalities

Prematurely born children are at higher risk of cognitive impairments and behavioral
disorders than full-term children. There is growing evidence of significant volumetric and
shape abnormalities in subcortical structures of premature neonates, which may be associated
to negative long-term neurodevelopmental outcomes. The general objective is to look directly
at the long-term neurodevelopmental implications of these neonatal subcortical structures
abnormalities. Investigators propose to develop biomarkers of prematurity by comparing the
morphological and diffusion properties of subcortical structures between preterm, with and
without associated brain injuries, and full-term neonates using brain MRI. By combining
subcortical morphological and diffusion properties, investigators hypothesize to be able to:
(1) delineate specific correlative relationships between structures regionally and
differentially affected by normal maturation and different patterns of white matter injury,
and (2) improve the specificity of neuroimaging to predict neurodevelopmental outcomes
earlier. The specific aims and general methodology are: 1) Build a new toolbox for neonatal
subcortical structures analyses that combine a group lasso-based analysis of significant
regions of shape changes, a structural correlation network analysis, a neonatal tractography,
and tensor-based analysis on tracts; 2) Ascertain biomarkers of prematurity in neonates with
different patterns of abnormalities using correlational and connectivity analysis within and
between structures features; 3) Assess the predictive potential of subcortical imaging on
neurodevelopmental outcomes by correlating neonatal imaging results with long-term
neurodevelopmental scores at 9 and 18 months, and 6-8 years, follow-up. In each of these
aims, investigators will use advanced neuroimaging analysis developed by their group and
collaborator, including multivariate tensor-based morphometry and multivariate tract-based
analysis. This application will provide the first complete subcortical network analysis in
both term and preterm neonates. In the first study of its kind for prematurity, investigators
will use sparse and multi-task learning to determine which of the biomarkers of prematurity
at birth are the best predictors of long-term outcome. Once implemented, these methods will
be available to compare subcortical structures for other pathologies in newborns and
children.

The last months of pregnancy are particularly important for the development of the child's
brain, and the consequences of premature birth on its development can be substantial.
Prematurely born children are at higher risk of various cognitive impairments and exhibits
more behavioral disorders than full-term born children. Thus early detection and management
of at risk children are essential. There is growing evidence of significant volumetric
abnormalities in subcortical structures of premature neonates, which may be associated to
negative long-term neurodevelopmental outcomes. Understanding these abnormalities could help
elucidate the underlying pathophysiology and enable early determination of at-risk patients,
both of which would inform the design of novel treatment strategies. However, to date there
is still a lack of sensitive, reliable, and accessible algorithms capable of characterizing
the influence of prematurity on the anatomy of neonatal brain subcortical structures. In
addition, few studies have looked directly at the long-term neurodevelopmental implications
of these neonatal subcortical structures abnormalities. Predicting long-term
neurodevelopmental outcomes early on - and preferably at neonatal ages - is likely to have a
transformative effect on their outcome. Our preliminary data indicate significant
morphological differences in the putamen, ventricles, corpus callosum, and thalamus between
preterm and term neonates. Investigators propose to develop biomarkers of prematurity by
statistically comparing the morphological and diffusion properties of subcortical structures
between preterm and term neonates using brain MRI. These results will further be used in a
sparse learning framework to predict long-term neurodevelopmental outcomes of prematurity.
Hypotheses: By combining subcortical morphological and diffusion properties, we will be able
to: (1) delineate specific correlative relationships between structures regionally and
differentially affected by normal maturation and different patterns of white matter injury,
and (2) improve the specificity of neuroimaging to predict neurodevelopmental outcomes
earlier. Aim 1: Build a new toolbox for neonatal subcortical structures analyses that combine
1) a group lasso-based analysis of significant regions of shape changes, 2) a structural
correlation network analysis, 3) a neonatal tractography, and 4) tensor-based analysis on
tracts. Aim 2: Ascertain biomarkers of prematurity in neonates with different patterns of
abnormalities. Aim 3: Assess the predictive potential of imaging and clinical features on
neurodevelopmental outcomes among premature children at 9 and 18 months and 6-8 years of age.
Impact: This application will provide the first complete subcortical network analysis in both
term and preterm neonates. In the first study of its kind for prematurity, investigators will
use sparse and multi-task learning to determine which of the biomarkers of prematurity at
birth are the best predictors of long-term outcome. The expected findings could improve the
ability to predict these outcomes and enable the design of early treatments - before years of
pathological brain development and symptoms occur.

Inclusion Criteria:

- Preterm birth (Gestational Age 21-36 weeks)

- English or Spanish speaking families

- PVL and Grade I and II IVH will be considered

Exclusion Criteria:

- Shunt

- Intubation, Cpap, Nasal Ventilation

- Chromosomal/Genetic abnormalities

- Mitochondrial/Metabolic Diseases

- Treatment for extracorporeal membrane oxygenation (ECMO)

- Grade III and IV IVH
We found this trial at
1
site
4650 Sunset Blvd
Los Angeles, California 90027
 (323) 660-2450
Phone: 323-361-5088
Childrens Hospital Los Angeles Children's Hospital Los Angeles is a 501(c)(3) nonprofit hospital for pediatric...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials